LINC00659 Inhibits Hepatocellular Carcinoma Malignant Progression by Blocking Aerobic Glycolysis through FUS Recruitment and SLC10A1 Modulation
Hepatocellular carcinoma (HCC) is a malignant type of liver cancer that poses severe threat to human health worldwide. Aerobic glycolysis is a hallmark of HCC and facilitates its progression. Solute carrier family 10 member 1 (SLC10A1) and long intergenic non-protein coding RNA 659 (LINC00659) were...
Saved in:
| Main Authors: | Bin Chen, Xin Xu, Wei Wu, Ke Zheng, Yijun Yu |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-01-01
|
| Series: | Analytical Cellular Pathology |
| Online Access: | http://dx.doi.org/10.1155/2023/5852963 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
By modulating miR‐525‐5p/Bax axis, LINC00659 promotes vascular endothelial cell apoptosis
by: Xizheng Zhu, et al.
Published: (2023-01-01) -
SLC50A1 inhibits the doxorubicin sensitivity in hepatocellular carcinoma cells through regulating the tumor glycolysis
by: Ganggang Wang, et al.
Published: (2024-12-01) -
Knockdown of SLC7A5 inhibits malignant progression and attenuates oxaliplatin resistance in gastric cancer by suppressing glycolysis
by: Yan Zhang, et al.
Published: (2025-03-01) -
LncRNA XIST promoted the stability of TLR9 mRNA in a FUS-dependent manner to facilitate aerobic glycolysis and proliferation in Th17/CD4+T cells
by: Wu Yan-ping, et al.
Published: (2022-05-01) -
LncRNA HOTAIR promotes aerobic glycolysis by recruiting Lin28 to induce inflammation and apoptosis in acute lung injury
by: Junjie Xie, et al.
Published: (2025-12-01)